United-Guardian (UG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on May 15, 2025, to elect six directors, vote on executive compensation matters, and ratify the independent auditor for 2025.
Only stockholders of record as of April 2, 2025, are entitled to vote; 4,594,319 shares of common stock are outstanding.
Proxy materials, including the annual report, are available online, and voting can be done by mail or internet.
Voting matters and shareholder proposals
Proposals include electing six directors, advisory votes on executive compensation and its frequency, and ratification of Grassi & Co. as auditor.
The board recommends annual advisory votes on executive compensation and supports all proposals.
Stockholder proposals for the 2026 meeting must be received by December 16, 2025, for inclusion in proxy materials.
Board of directors and corporate governance
The board consists of six directors, five of whom are independent under NASDAQ rules.
Board committees include Audit, Compensation, and Investment; only the Audit Committee has a chairman.
The board meets regularly, with independent directors holding executive sessions twice a year.
Director nominations are handled by the full board, with final selections by a majority of independent directors.
Latest events from United-Guardian
- Net sales and income fell, but pharmaceuticals and medical lubricants posted year-over-year growth.UG
Q4 202527 Mar 2026 - Sales and earnings fell year-over-year, but pharma and lubricant sales showed growth.UG
Q2 20258 Aug 2025 - Net income and sales rose on strong cosmetic demand; pharma sales to recover.UG
Q3 202413 Jun 2025 - Net sales and income soared, driven by cosmetic ingredient demand and pharma recovery.UG
Q2 202413 Jun 2025 - Sales and net income dropped sharply in Q1 2025, led by a 63% fall in cosmetic ingredient sales.UG
Q1 20256 Jun 2025 - Net income climbed 26% to $3.25M on robust sales growth in China.UG
Q4 20245 Jun 2025